Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Market outline
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by products
• Market overview
• Consumables
• Instruments
PART 07: Market segmentation by end-user
• Market overview
• Hospitals and clinics
• Clinical diagnostic laboratories
• Homecare settings
PART 08: Geographical segmentation
• Market overview
• POC blood gas and electrolyte market in Americas
• POC blood gas and electrolyte market in EMEA
• POC blood gas and electrolyte market in APAC
PART 09: Decision framework
PART 10: Drivers and challenges
• Market drivers
• Market challenges
PART 11: Market trends
• Paradigm shift from benchtop to portable POC blood gas and electrolyte devices
• Data management and connectivity through interoperability
• Shift from traditional central laboratory blood gas analysis to near-patient site testing
PART 12: Vendor landscape
• Competitive landscape
PART 13: Key vendor analysis
• Alere
• F. Hoffmann-La Roche
• Instrumentation Laboratory
• Radiometer
• Other prominent vendors
PART 14: Appendix
• List of abbreviations
[List of Exhibits]
Exhibit 01: Flow of the market for POC blood gas and electrolyte market 2016
Exhibit 02: Advantages of POC blood gas and electrolyte devices
Exhibit 03: Global POC blood gas and electrolyte market 2016-2021 ($ millions)
Exhibit 04: Five forces analysis
Exhibit 05: Global POC blood gas and electrolyte market by product 2016
Exhibit 06: Global POC blood gas and electrolyte market by consumables: Overview
Exhibit 07: Global POC blood gas and electrolyte market by consumables 2016-2021 ($ millions)
Exhibit 08: Market representation of the consumables segment of POC blood gas and electrolyte 2016-2021
Exhibit 09: Market overview of POC blood gas and electrolyte by instruments 2016
Exhibit 10: Global POC blood gas and electrolyte market by instruments 2016-2021 ($ millions)
Exhibit 11: Market representation of the instrument segment of POC blood gas and electrolyte (2016-2021)
Exhibit 12: Segmentation of global POC blood gas and electrolyte market by end-user 2016
Exhibit 13: Global POC blood gas and electrolyte market by end-user (2016)
Exhibit 14: Buying criteria analysis: Global POC blood gas and electrolyte market 2016
Exhibit 15: Global POC blood gas and electrolyte market by geography in 2016 and 2021 ($ millions)
Exhibit 16: Market overview: POC blood gas and electrolyte market in Americas
Exhibit 17: Global POC blood gas and electrolyte market in Americas 2016-2021 ($ millions)
Exhibit 18: Average length of stay (ALOS) for disease of the respiratory systems in the in-patient department for EMEA 2014
Exhibit 19: Market overview: POC blood gas and electrolyte market in EMEA
Exhibit 20: Global POC blood gas and electrolyte market in EMEA 2016-2021 ($ millions)
Exhibit 21: Market overview: POC blood gas and electrolyte market in APAC
Exhibit 22: Global POC blood gas and electrolyte market in APAC 2016-2021($ millions)
Exhibit 23: Global increase in older population from 2015 and 2030 (%)
Exhibit 24: Advantage of POC testing
Exhibit 25: Competitive structure analysis of global POC blood gas and electrolyte market 2016
Exhibit 26: Market penetration of key vendors in global POC blood gas and electrolyte market 2016
Exhibit 27: Strategic success factors for companies in global POC blood gas and electrolyte market 2016
Exhibit 28: Alere: Key highlights
Exhibit 29: Alere: Strength assessment
Exhibit 30: Alere: Strategy assessment
Exhibit 31: Alere: Opportunity assessment
Exhibit 32: F. Hoffmann-La Roche: Key highlights
Exhibit 33: F. Hoffmann-La Roche: Strength assessment
Exhibit 34: F. Hoffmann-La Roche: Strategy assessment
Exhibit 35: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 36: Instrumentation Laboratory: Key highlights
Exhibit 37: Instrumentation Laboratory: Strength assessment
Exhibit 38: Instrumentation Laboratory: Strategy assessment
Exhibit 39: Instrumentation Laboratory: Opportunity assessment
Exhibit 40: Radiometer: Key highlights
Exhibit 41: Radiometer: Strength assessment
Exhibit 42: Radiometer: Strategy assessment
Exhibit 43: Radiometer: Opportunity assessment
【掲載企業】
Alere, F. Hoffmann-La Roche, Instrumentation Laboratory, Radiometer, Abbott, Bayer, Cornley, Convergent Technologies, Edan Instruments, Erba Diagnostics, Fortress Diagnostics, i.SENS, JOKOH, LifeHealth, Medica, Nova Biomedical, OPTI Medical (Idexx), Perlong Medical, SENSACORE, Siemens Healthineers, Sphere Medical, and ZOLL Medical.
【資料のキーワード】
POC血液ガス・電解質、消耗品、計器
【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。